# Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

> **NCT05174468** · — · TERMINATED · sponsor: **Breathe BioMedical Inc** · enrollment: 28 (actual)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05174468
- **Lead sponsor:** Breathe BioMedical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-22
- **Primary completion:** 2023-07-12
- **Final completion:** 2023-07-12
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Change in sponsor's business strategy (disease focus changed to breast cancer)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05174468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05174468, "Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05174468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*